4
Changes in Ownership
Stoke Therapeutics, Inc. Filed Acc 0001181556-26-000005
Director sold 605 shares at $36.80 ($22,264)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| LEVIN ARTHUR A Director | 2026-03-13 | Sale 10b5-1 | −605 | $36.80 | $22,264 | 4,237 | D |
| Open-market sales · 605 sh · avg $36.80 · $22,264 | |||||||
Loading xslF345X05/form4-03172026_090352.xml…